Connolly Jenna G, Plant Leigh D
Department of Pharmaceutical Sciences and the Center for Drug Discovery, The School of Pharmacy and Pharmaceutical SciencesBouvé College of Health Sciences, Northeastern University, Boston, Massachusetts, United States.
Physiology (Bethesda). 2025 Mar 1;40(2):0. doi: 10.1152/physiol.00034.2024. Epub 2024 Nov 5.
The small ubiquitin-like modifier (SUMO) protein pathway governs a panoply of vital biological processes including cell death, proliferation, differentiation, metabolism, and signal transduction by diversifying the functions, half-lives, and partnerships of target proteins in situ. More recently, SUMOylation has emerged as a key regulator of ion homeostasis and excitability across multiple tissues due to the regulation of a plethora of ion channels expressed in a range of tissue subtypes. Altogether, the balance of SUMOylation states among relevant ion channels can result in graded biophysical effects that tune excitability and contribute to a range of disease states including cardiac arrhythmia, epilepsy, pain transmission, and inflammation. Here, we consolidate these concepts by focusing on the role of ion channel SUMOylation in the central nervous system, peripheral nervous system, and cardiovascular system. In addition, we review what is known about the enigmatic factors that regulate the SUMO pathway and consider the emerging role of small molecule SUMO modulators as potential therapeutics in a range of diseases.
小泛素样修饰物(SUMO)蛋白途径通过在原位使靶蛋白的功能、半衰期和伙伴关系多样化,从而掌控着一系列重要的生物学过程,包括细胞死亡、增殖、分化、代谢和信号转导。最近,由于对一系列组织亚型中表达的众多离子通道的调节,SUMO化已成为多种组织中离子稳态和兴奋性的关键调节因子。总之,相关离子通道之间SUMO化状态的平衡可导致分级生物物理效应,从而调节兴奋性,并导致包括心律失常、癫痫、疼痛传递和炎症在内的一系列疾病状态。在这里,我们通过关注离子通道SUMO化在中枢神经系统、外周神经系统和心血管系统中的作用来整合这些概念。此外,我们回顾了已知的调节SUMO途径的神秘因素,并考虑小分子SUMO调节剂作为一系列疾病潜在治疗药物的新兴作用。